Chronic pulpitis often leads to post-root canal therapy (RCT) complications. Wuwei Xiaodu Drink (WWXDD), a traditional anti-inflammatory formula, may enhance RCT efficacy. The objective was to assess WWXDD combined with RCT for chronic pulpitis, focusing on pain, inflammation, tissue repair, and safety. A retrospective study of 600 patients (300 RCT only vs 300 RCT + 14-day WWXDD) was conducted. Outcomes included pain (Visual Analog Scale), inflammatory markers (C-reactive protein, tumor necrosis factor-alpha, interleukin-6, interleukin-8), growth factors (basic fibroblast growth factor, vascular endothelial growth factor, bone morphogenetic protein-2), periodontal indices (Gingival Index, Plaque Index, Periodontal Probing Depth), and adverse events. WWXDD group showed lower Visual Analog Scale scores (days 7/14/28, P < .001), reduced inflammation (C-reactive protein: 7.13 vs 8.54 mg/L; tumor necrosis factor-alpha: 48.57 vs 57.28 ng/L), improved periodontal indices (Gingival Index: 0.71 vs 0.84; Periodontal Probing Depth: 1.43 vs 1.68 mm, P < .001), and higher growth factors (basic fibroblast growth factor: 43.75 vs 41.22 pg/μL). Adverse events were lower (6.00% vs 11.00%, P = .028), with superior efficacy (94.33% vs 89.33%, P = .025). WWXDD synergizes with RCT to alleviate pain, suppress inflammation, enhance repair, and improve safety. Integrating traditional medicine optimizes chronic pulpitis management.
Xuan et al. (Fri,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: